Pro Share Advisors LLC Enanta Pharmaceuticals Inc Transaction History

Pro Share Advisors LLC

$39.7 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 02, 2023	BUY	$40.77 - $53.73 $15,247 - $20,095	374 Added 8.43%	4,808 $223,000
Q3 2022 Nov 04, 2022	BUY	$48.29 - $71.27 $4,442 - $6,556	92 Added 2.12%	4,434 $230,000
Q2 2022 Aug 01, 2022	SELL	$38.13 - $76.93 $79,729 - $160,860	-2,091 Reduced 32.5%	4,342 $206,000
Q1 2022 May 10, 2022	SELL	$56.06 - $74.11 $67,272 - $88,932	-1,200 Reduced 15.72%	6,433 $458,000
Q4 2021 Feb 08, 2022	BUY	$60.19 - $97.37 $23,112 - $37,390	384 Added 5.3%	7,633 $570,000
Q3 2021 Nov 12, 2021	SELL	$41.02 - $58.65 $76,502 - $109,382	-1,865 Reduced 20.46%	7,249 $412,000
Q2 2021 Aug 13, 2021	BUY	$43.76 - $53.11 $28,356 - $34,415	648 Added 7.65%	9,114 $401,000
Q1 2021 May 14, 2021	BUY	$41.69 - $54.95 $33,518 - $44,179	804 Added 10.49%	8,466 $418,000
Q4 2020 Feb 09, 2021	BUY	$41.16 - $47.47 $72,770 - $83,926	1,768 Added 30.0%	7,662 $323,000
Q3 2020 Nov 13, 2020	SELL	$43.36 - $53.53 $6,980 - $8,618	-161 Reduced 2.66%	5,894 $270,000
Q2 2020 Aug 03, 2020	BUY	$46.37 - $57.58 $91,209 - $113,259	1,967 Added 48.12%	6,055 $304,000
Q1 2020 May 15, 2020	SELL	$40.22 - $62.0 $118,367 - $182,466	-2,943 Reduced 41.86%	4,088 $210,000
Q4 2019 Feb 12, 2020	SELL	$57.95 - $66.61 $37,957 - $43,629	-655 Reduced 8.52%	7,031 $434,000
Q3 2019 Nov 12, 2019	SELL	$60.08 - $88.17 $17,303 - $25,392	-288 Reduced 3.61%	7,686 $462,000
Q2 2019 Aug 13, 2019	SELL	$81.3 - $97.35 $73,576 - $88,101	-905 Reduced 10.19%	7,974 $673,000
Q1 2019 May 15, 2019	BUY	$69.08 - $105.66 $6,079 - $9,298	88 Added 1.0%	8,879 $848,000
Q4 2018 Feb 14, 2019	SELL	$65.41 - $84.65 $102,039 - $132,054	-1,560 Reduced 15.07%	8,791 $623,000
Q3 2018 Nov 14, 2018	SELL	$85.46 - $126.37 $35,978 - $53,201	-421 Reduced 3.91%	10,351 $885,000
Q2 2018 Aug 13, 2018	SELL	$81.85 - $120.51 $42,070 - $61,942	-514 Reduced 4.55%	10,772 $1.25 Million
Q1 2018 May 14, 2018	SELL	$57.91 - $92.15 $100,589 - $160,064	-1,737 Reduced 13.34%	11,286 $913,000
Q4 2017 Feb 14, 2018	BUY	$45.65 - $59.37 $42,226 - $54,917	925 Added 7.65%	13,023 $764,000
Q3 2017 Nov 13, 2017	BUY	$37.91 - $46.8 $27,408 - $33,836	723 Added 6.36%	12,098 $566,000
Q2 2017 Aug 11, 2017	BUY	N/A	11,375	11,375 $409,000

Others Institutions Holding ENTA

# of Institutions

110

Shares Held

21.1M

Call Options Held

4.8K

Put Options Held

4.6K

Farallon Capital Management LLC San Francisco, CA

2.11M
Shares

$18 Million
0.11% of portfolio
Vanguard Group Inc Valley Forge, PA

1.98M
Shares

$17 Million
0.0% of portfolio
Black Rock Inc. New York, NY

1.85M
Shares

$15.8 Million
0.0% of portfolio
Krensavage Asset Management, LLC New York, NY

1.5M
Shares

$12.8 Million
8.7% of portfolio
Morgan Stanley New York, NY

1.1M
Shares

$9.44 Million
0.0% of portfolio

View Full List

About ENANTA PHARMACEUTICALS INC

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $177M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

More about ENTA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Account